See every side of every news story
Published loading...Updated

Apple and Masimo Back in Court over Import Ban Appeal

UNITED STATES, JUL 7 – Apple seeks to reverse a ban on Apple Watch imports after a 2023 ruling found it infringed Masimo's pulse oximetry patents, affecting millions of users, Apple said.

  • In early 2024, Apple’s legal team presented arguments to the U.S. Court of Appeals to challenge a trade prohibition on sales of Apple Watch models equipped with blood-oxygen sensors within the United States.
  • The ban followed a 2023 U.S. International Trade Commission ruling that found Apple infringed Masimo's patents and reinstated the import ban after a brief stay in December 2023.
  • To comply with regulations in the U.S., Apple has deactivated the blood-oxygen monitoring feature on its newest watch models sold domestically, while leaving this functionality intact on devices offered outside the country.
  • Apple's lawyer argued the ban unjustly harmed millions of users since Masimo's competing smartwatch was only a prototype when its 2021 complaint was filed, while Masimo countered Apple was trying to "rewrite the law."
  • The Federal Circuit has yet to issue a final ruling, but the ongoing dispute has partly contributed to a significant decline in Apple's smartwatch shipments in 2024.
Insights by Ground AI
Does this summary seem wrong?

15 Articles

Apple has been campaigning for a possible patent infringement with Masimo at Apple Watch since 2021. Now an appeal has been filed.

·Germany
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

machash.com broke the news in on Monday, July 7, 2025.
Sources are mostly out of (0)